Viral vectors in gene therapy: Where do we stand in 2023?

K Lundstrom - Viruses, 2023 - mdpi.com
Viral vectors have been used for a broad spectrum of gene therapy for both acute and
chronic diseases. In the context of cancer gene therapy, viral vectors expressing anti-tumor …

Twenty‐five years of research about adipogenic adenoviruses: A systematic review

M Akheruzzaman, V Hegde, NV Dhurandhar - Obesity Reviews, 2019 - Wiley Online Library
Infectious etiology is implicated in chronic diseases such as gastric ulcer or atherosclerosis.
However,“infection” is a recent term in the field of obesity. Since the first report in 1982 of …

Gene therapy cargoes based on viral vector delivery

K Lundstrom - Current Gene Therapy, 2023 - benthamdirect.com
Viral vectors have been proven useful in a broad spectrum of gene therapy applications due
to their possibility to accommodate foreign genetic material for both local and systemic …

Adenovirus type 36 regulates adipose stem cell differentiation and glucolipid metabolism through the PI3K/Akt/FoxO1/PPARγ signaling pathway

Y Jiao, X Liang, J Hou, Y Aisa, H Wu, Z Zhang… - Lipids in Health and …, 2019 - Springer
Background This study aims to investigate the molecular mechanism of Adenovirus type 36
(Ad36) in adipocyte differentiation and glucolipid metabolism. Methods Rat obesity model …

[HTML][HTML] E4orf1: The triple agent of adenovirus–Unraveling its roles in oncogenesis, infectious obesity and immune responses in virus replication and vector therapy

L Göttig, S Schreiner - Tumour Virus Research, 2024 - Elsevier
Abstract Human Adenoviruses (HAdV) are nearly ubiquitous pathogens comprising
numerous sub-types that infect various tissues and organs. Among many encoded proteins …

Hyperinsulinemia or insulin resistance: What impacts the progression of Alzheimer's disease?

V Hegde, NV Dhurandhar… - Journal of Alzheimer's …, 2019 - content.iospress.com
Type 2 diabetes mellitus (T2D), which is often accompanied by hyperinsulinemia and insulin
resistance, is associated with an increased risk for developing mild cognitive impairment …

E4orf1: a protein for enhancing glucose uptake despite impaired proximal insulin signaling

AA Shastri, V Hegde, S Peddibhotla, Z Feizy… - PLoS …, 2018 - journals.plos.org
Background Type 2 diabetes is often linked with impaired proximal insulin signaling. Hence,
a therapeutic agent that enhances cellular glucose uptake without requiring proximal insulin …

E4orf1 enhances glucose uptake independent of proximal insulin signaling

HN Na, V Hegde, O Dubuisson, NV Dhurandhar - PLoS One, 2016 - journals.plos.org
Impaired proximal insulin signaling is often present in diabetes. Hence, approaches to
enhance glucose disposal independent of proximal insulin signaling are desirable …

Reducing endogenous insulin is linked with protection against hepatic steatosis in mice

M Akheruzzaman, V Hegde, AC Shin… - Nutrition & …, 2020 - nature.com
Background Obesity and type 2 diabetes (T2D) are closely associated with hepatic steatosis
(HS), which if untreated can advance to serious liver conditions. Since insulin promotes …

Nanoparticle-mediated in vitro delivery of E4orf1 to preadipocytes is a clinically relevant delivery system to improve glucose uptake

Z Feizy, S Peddibhotla, S Khan, V Hegde… - International Journal of …, 2020 - nature.com
Objective Impaired glycemic control is a common comorbidity of obesity. E4orf1 (E4), an
adenovirus-derived protein, reduces the activity of insulin receptor substrate (IRS), yet …